檢索結果 - Zdenka Hašková
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration 由 Arshad M. Khanani, Sunil Patel, Philip J. Ferrone, Aaron Osborne, Jayashree Sahni, Susanna M. Grzeschik, Karen Basu, Jason S. Ehrlich, Zdenka Hašková, Pravin U. Dugel
出版 2020Artigo -
9
Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin 由 Shivani Srivastava, David Pelloso, Hailin Feng, Larry Voiles, David Y. Lewis, Zdenka Hašková, Margaret Whitacre, Stephen Trulli, Yi-Jiun Chen, John Toso, Zdenka Jonak, Hua-Chen Chang, Michael J. Robertson
出版 2013Artigo -
10
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion 由 Lars‐Olof Hattenbach, Francis Abreu, Pablo Arrisi, Karen Basu, Carl J. Danzig, Robyn H. Guymer, Zdenka Hašková, Jeffrey S. Heier, Aachal Kotecha, Ying Liu, Anat Loewenstein, András Seres, Jeffrey R. Willis, Charles C. Wykoff, Liliana P Paris
出版 2023Artigo -
11
-
12
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion 由 Ramin Tadayoni, Liliana P Paris, Carl J. Danzig, Francis Abreu, Arshad M. Khanani, Christopher Brittain, Timothy Y. Y. Lai, Zdenka Hašková, Taiji Sakamoto, Aachal Kotecha, Patricio G. Schlottmann, Ying Liu, András Seres, Anne-Cecile Retiere, Jeffrey R. Willis, Young Hee Yoon
出版 2024Artigo -
13
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised,... 由 Charles C. Wykoff, Francis Abreu, Anthony P. Adamis, Karen Basu, David Eichenbaum, Zdenka Hašková, Hugh Lin, Anat Loewenstein, Shaun Mohan, Ian Pearce, Taiji Sakamoto, Patricio G. Schlottmann, David G. Silverman, Jennifer K. Sun, John A. Wells, Jeffrey R. Willis, Ramin Tadayoni, Thomas M. Aaberg, Ashkan M. Abbey, Elmira Abdulaeva, Santiago Abengoechea, Prema Abraham, Thomas Ach, Serrhel G. Adams, Alfredo Adán, Sean D. Adrean, Hansjürgen Agostini, Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel, Jaroslava Dusova, David Eichenbaum, Bora Eldem
出版 2022Artigo -
14
Faricimab Treat-and-Extend for Diabetic Macular Edema 由 Tien Yin Wong, Zdenka Hašková, Kemal Asik, Caroline R. Baumal, Karl G. Csaky, Nicole Eter, Jane A. Ives, Glenn J. Jaffe, Jean‐François Korobelnik, Hugh Lin, Toshinori Murata, Paisan Ruamviboonsuk, Patricio G. Schlottmann, András Seres, David G. Silverman, Xiaodong Sun, Yannan Tang, John A. Wells, Young Hee Yoon, Charles C. Wykoff, Thomas M. Aaberg, Ashkan M. Abbey, Elmira Abdulaeva, Santiago Abengoechea, Prema Abraham, Thomas Ach, Serrhel G. Adams, Alfredo Adán, Sean D. Adrean, Hansjürgen Agostini, Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel
出版 2023Artigo
相關主題
Medicine
Ophthalmology
Bevacizumab
Chemotherapy
Internal medicine
Surgery
Diabetes mellitus
Diabetic retinopathy
Endocrinology
Visual acuity
Clinical trial
Macular edema
Ranibizumab
Aflibercept
Dosing
Biology
Branch retinal vein occlusion
Clinical endpoint
Diabetic macular edema
Fundus (uterus)
Macular degeneration
Randomized controlled trial
Regimen
Retinal
Adverse effect
Artificial intelligence
Central retinal vein occlusion
Chemistry
Computer science
Confidence interval